As of the latest SEC filings, NEURAXPHARM ARZNEIMITTEL GMBH (INVFAR) is held by 4 institutional funds. The largest fund shareholder is Partners Group Private Equity Fund, LLC (CEF-47247), holding an estimated $1,944,213.44 in market value, representing 0.01% of its portfolio.
Funds holding NEURAXPHARM ARZNEIMITTEL GMBH (INVFAR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- INVFAR
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
-
Partners Group Private Equity Fund, LLC
|
CEF | Independent / Boutique | 0.01% | $1,944,213.44 | 1,676,690 | Mar 31, 2026 | Jun 1, 2026 |
|
JHLN
John Hancock Global Senior Loan ETF
|
ETF | John Hancock | 0.14% | $833,896.62 | 722,919 | Mar 31, 2026 | May 29, 2026 |
|
-
Partners Group Private Equity Fund, LLC
|
CEF | Independent / Boutique | 0.00% | $604,794.90 | 521,941 | Mar 31, 2026 | Jun 1, 2026 |
|
JHLN
John Hancock Global Senior Loan ETF
|
ETF | John Hancock | 0.05% | $319,208.08 | 277,081 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)